sb 202190 has been researched along with Carcinoma, Basal Cell, Pigmented in 1 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hill, NT | 1 |
| Zhang, J | 1 |
| Leonard, MK | 1 |
| Lee, M | 1 |
| Shamma, HN | 1 |
| Kadakia, M | 1 |
1 other study available for sb 202190 and Carcinoma, Basal Cell, Pigmented
| Article | Year |
|---|---|
1α, 25-Dihydroxyvitamin D₃ and the vitamin D receptor regulates ΔNp63α levels and keratinocyte proliferation.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival | 2015 |